Z Gastroenterol 2004; 42(9): 1029-1032
DOI: 10.1055/s-2004-813515
Leitlinien

© Karl Demeter Verlag im Georg Thieme Verlag KG Stuttgart · New York

Pouchitis

PouchitisE. F. Stange1 , H.-J Buhr2
  • 1Robert-Bosch-Krankenhaus, Zentrum für Innere Medizin, Stuttgart
  • 2Chirurgische Klinik I, Charité, Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin
Further Information

Publication History

Publication Date:
29 September 2004 (online)

Präambel

Insgesamt ist die Datenlage zu Definition, Therapie und Prognose der Pouchitis sehr begrenzt. Bessere Daten liegen zur langjährigen Nachbeobachtung vor [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11].

Da der Begriff „Pouchitis” jedwede Form einer Entzündung umschreibt unabhängig von der Ursache, sollte eine bessere Nomenklatur (Pouchitis im engeren Sinne, idiopathische Pouchitis, prim./sek. Pouchitis) erarbeitet werden [12]. Im vorliegenden Text wird unter dem Begriff „Pouchitis” ausschließlich die idiopathische bzw. primäre Pouchitis gefasst. Die Verlaufsformen der Pouchitis sind ebenfalls in der Literatur nicht einheitlich definiert, wodurch insbesondere bei der Therapie kaum verwertbare Daten existieren. Es wird versucht, eine plausible und klinisch relevante Klassifikation vorzuschlagen. Auf der Basis von klinischen und experimentellen Untersuchungen muss davon ausgegangen werden, dass die Pouchitis eine Remanifestation der chronisch entzündlichen Darmerkrankung unter neuen Bedingungen darstellt. Die Proktokolektomie bei Colitis ulcerosa führt daher nicht zu einer Heilung der Grunderkrankung. Die restaurative Proktokolektomie mit ileoanaler Pouchanlage schafft letztlich die Bedingungen zur Entstehung der Pouchitis mit bisher nicht sicher abzuschätzender Häufigkeit und Langzeitprognose. Unbeschadet hiervon ist dieser Eingriff die Methode der Wahl bei klarer Indikation bei Patienten mit Colitis ulcerosa. Der Wert dieses Eingriffs und der Benefit für die Patienten in definierten klinischen Situationen ist unbestritten.

Literatur

  • 1 Buhr H J, Heuschen U A, Stern J. et al . Kontinenz-erhaltende Operation nach Proktokolektomie. Indikationen, Technik und Ergebnisse.  Chirurg. 1993;  64 601-613 (III)
  • 2 Kartheuser A H, Parc R, Penna C P. et al . Ileal pouch-anal anastomosis as the first choice operation in patients with familial adenomatous polyposis: a ten-year experience.  Surgery. 1996;  119 615-623 (III)
  • 3 Stahlberg D, Gullberg K, Liljeqvist L. et al . Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors.  Dis Colon Rectum. 1996;  39 1012-1018 (IIa)
  • 4 Meagher A P, Farouk R, Dozois R R. et al . J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients.  Br J Surg. 1998;  85 800-803 (III)
  • 5 Hurst R D, Chung T P, Rubin M. et al . The implications of acute pouchitis on the long-term functional results after restorative proctocolectomy.  Inflamm Bowel Dis. 1998;  4 280-284 (III)
  • 6 Tiainen J, Matikainen M. Long-term clinical outcome and anemia after restorative proctocolectomy for ulcerative colitis.  Scand J Gastroenterol. 2000;  35 1170-1173 (III)
  • 7 Tiainen J, Matikainen M. Health-related quality of life after ileal J-pouch-anal anastomosis for ulcerative colitis: long-term results.  Scand J Gastroenterol. 1999;  34 601-605 (III)
  • 8 Seidel S A, Peach S E, Newman M. et al . Ileoanal pouch procedures: clinical outcomes and quality-of-life assessment.  Am Surg. 1999;  65 40-46 (III)
  • 9 Tiainen J, Matikainen M, Aitola P. et al . Histological and macroscopic changes in the pelvic pouch: long-term follow up after restorative proctocolectomy for ulcerative colitis (UC).  Colorectal Dis. 2001;  3 28-32 (III)
  • 10 Heuschen U A, Autschbach F, Allemeyer E H. et al . Long-term follow-up after ileoanal pouch procedure: algorithm for diagnosis, classification, and management of pouchitis.  Dis Colon Rectum. 2001;  44 487-499 (IIb)
  • 11 Cheifetz A, Itzkowitz S. The diagnosis and treatment of pouchitis in inflammatory bowel disease.  J Clin Gastroenterol. 2004;  38 44-50 (IV)
  • 12 Mahadevan U, Sandborn W J. Diagnosis and management of pouchitis.  Gastroenterology. 2003;  124 1636-1650 (IV)
  • 13 Hurst R D, Molinari M, Chung T P. et al . Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy.  Arch Surg. 1996;  131 497-500; discussion 501 - 502
  • 14 Lohmuller J L, Pemberton J H, Dozois R R. et al . Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis.  Ann Surg. 1990;  211 622-627; discussion 627 - 629 (III)
  • 15 Nicholls R J, Banerjee A K. Pouchitis: risk factors, etiology, and treatment.  World J Surg. 1998;  22 347-351 (IV)
  • 16 Penna C, Dozois R, Tremaine W. et al . Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis.  Gut. 1996;  38 234-239 (IIb)
  • 17 Fleshner P R, Vasiliauskas E A, Kam L Y. et al . High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis.  Gut. 2001;  49 671-677 (IIb)
  • 18 Yasuda N, Thomas P, Ellis H. et al . Perinuclear anti-neutrophil cytoplasmic antibodies in ulcerative colitis after restorative proctocolectomy do not correlate with the presence of pouchitis.  Scand J Gastroenterol. 1998;  33 509-513 (III)
  • 19 Shanahan F. Neutrophil autoantibodies in inflammatory bowel disease: are they important?.  Gastroenterology. 1994;  107 586-589 (IV)
  • 20 Esteve M, Mallolas J, Klaassen J. et al . Antineutrophil cytoplasmic antibodies in sera from colectomised ulcerative colitis patients and its relation to the presence of pouchitis.  Gut. 1996;  38 894-898 (III)
  • 21 Reumaux D, Colombel J F, Masy E. et al . Anti-neutrophil cytoplasmic auto-antibodies (ANCA) in ulcerative colitis (UC): no relationship with disease activity.  Inflamm Bowel Dis. 2000;  6 270-274 (IIb)
  • 22 Schmidt C M, Lazenby A J, Hendrickson R J. et al . Preoperative terminal ileal and colonic resection histopathology predicts risk of pouchitis in patients after ileoanal pull-through procedure.  Ann Surg. 1998;  227 654-662 (III)
  • 23 Gustavsson S, Weiland L H, Kelly K A. Relationship of backwash ileitis to ileal pouchitis after ileal pouch-anal anastomosis.  Dis Colon Rectum. 1987;  30 25-28 (III)
  • 24 Thoeni R F, Fell S C, Engelstad B. et al . Ileoanal pouches: comparison of CT, scintigraphy, and contrast enemas for diagnosing postsurgical complications.  Am J Roentgenol. 1990;  154 73-78 (III)
  • 25 Libicher M, Scharf J, Wunsch A. et al . MRI of pouch-related fistulas in ulcerative colitis after restorative proctocolectomy.  J Comput Assist Tomogr. 1998;  22 664-668 (III)
  • 26 Hrung J M, Levine M S, Rombeau J L. et al . Total proctocolectomy and ileoanal pouch: the role of contrast studies for evaluating postoperative leaks.  Abdom Imaging. 1998;  23 375-379 (III)
  • 27 Solomon M J, McLeod R S, O’Connor B I. et al . Assessment of peripouch inflammation after ileoanal anastomosis using endoluminal ultrasonography.  Dis Colon Rectum. 1995;  38 182-187 (III)
  • 28 Sandborn W J, Tremaine W J, Batts K P. et al . Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index.  Mayo Clin Proc. 1994;  69 409-415 (III)
  • 29 Shen B, Achkar J P, Lashner B A. et al . Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis.  Gastroenterology. 2001;  121 261-267 (IIb)
  • 30 Kuisma J, Nuutinen H, Luukkonen P. et al . Long term metabolic consequences of ileal pouch-anal anastomosis for ulcerative colitis.  Am J Gastroenterol. 2001;  96 3110-3116 (III)
  • 31 Sarigol S, Wyllie R, Gramlich T. et al . Incidence of dysplasia in pelvic pouches in pediatric patients after ileal pouch-anal anastomosis for ulcerative colitis.  J Pediatr Gastroenterol Nutr. 1999;  28 429-434 (III)
  • 32 Veress B, Reinholt F P, Lindquist K. et al . Long-term histomorphological surveillance of the pelvic ileal pouch: dysplasia develops in a subgroup of patients.  Gastroenterology. 1995;  109 1090-1097 (III)
  • 33 Stallmach A, Moser C, Hero-Gross R. et al . Pattern of mucosal adaptation in acute and chronic pouchitis.  Dis Colon Rectum. 1999;  42 1311-1317 (III)
  • 34 Shepherd N A, Healey C J, Warren B F. et al . Distribution of mucosal pathology and an assessment of colonic phenotypic change in the pelvic ileal reservoir.  Gut. 1993;  34 101-105 (III)
  • 35 Setti C arraro P, Talbot I C, Nicholls R J. Longterm appraisal of the histological appearances of the ileal reservoir mucosa after restorative proctocolectomy for ulcerative colitis.  Gut. 1994;  35 1721-1727 (III)
  • 36 Setti C arraro PG, Talbot I C, Nicholls J R. Patterns of distribution of endoscopic and histological changes in the ileal reservoir after restorative proctocolectomy for ulcerative colitis. A long-term follow-up study.  Int J Colorectal Dis. 1998;  13 103-107 (III)
  • 37 Gullberg K, Stahlberg D, Liljeqvist L. et al . Neoplastic transformation of the pelvic pouch mucosa in patients with ulcerative colitis.  Gastroenterology. 1997;  112 1487-1492 (III)
  • 38 Fruin A B, El-Zammer O, Stucchi A F. et al . Colonic metaplasia in the ileal pouch is associated with inflammation and is not the result of long-term adaptation.  J Gastrointest Surg. 2003;  7 246-253 (IIb)
  • 39 Stahlberg D, Veress B, Tribukait B. et al . Atrophy and neoplastic transformation of the ileal pouch mucosa in patients with ulcerative colitis and primary sclerosing cholangitis: a case control study.  Dis Colon Rectum. 2003;  46 770-778 (III)
  • 40 Thompson-Fawcett M W, Marcus V, Redston M. et al . Risk of dysplasia in long-term ileal pouches and pouches with chronic pouchitis.  Gastroenterology. 2001;  121 275-281 (IIb)
  • 41 Shen B, Achkar J P, Lashner B A. et al . Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis.  Am J Gastroenterol. 2002;  97 972-977 (IIb)
  • 42 Sandborn W J, McLeod R, Jewell D P. Medical therapy for induction and maintenance of remission in pouchitis: a systematic review.  Inflamm Bowel Dis. 1999;  5 33-39 (Ia)
  • 43 Gionchetti P, Rizzello F, Venturi A. et al . Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.  Gastroenterology. 2000;  119 305-309 (Ib)
  • 44 Svaninger G, Nordgren S, Oresland T. et al . Incidence and characteristics of pouchitis in the Kock continent ileostomy and the pelvic pouch.  Scand J Gastroenterol. 1993;  28 695-700 (III)
  • 45 Rauh S M, Schoetz D J Jr, Roberts P L. et al . Pouchitis - is it a wastebasket diagnosis?.  Dis Colon Rectum. 1991;  34 685-689 (III)
  • 46 Shen B, Achkar J P, Lashner B A. et al . A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.  Inflamm Bowel Dis. 2001;  7 301-305 (Ib)
  • 47 Nygaard K, Bergan T, Bjorneklett A. et al . Topical metronidazole treatment in pouchitis.  Scand J Gastroenterol. 1994;  29 462-467 (III)
  • 48 Gionchetti P, Rizzello F, Helwig U. et al . Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial.  Gastroenterology. 2003;  124 1202-1209 (Ib)
  • 49 Madden M V, McIntyre A S, Nicholls R J. Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis.  Dig Dis Sci. 1994;  39 1193-1196 (Ib)
  • 50 Mimura T, Rizzello F, Helwig U. et al . Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis.  Aliment Pharmacol Ther. 2002;  16 909-917 (III)
  • 51 Gionchetti P, Rizzello F, Venturi A. et al . Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis.  Aliment Pharmacol Ther. 1999;  13 713-718 (III)
  • 52 Wischmeyer P, Pemberton J H, Phillips S F. Chronic pouchitis after ileal pouch-anal anastomosis: responses to butyrate and glutamine suppositories in a pilot study.  Mayo Clin Proc. 1993;  68 978-981 (Ib)
  • 53 Shepherd N A, Hulten L, Tytgat G N. et al . Pouchitis.  Int J Colorectal Dis. 1989;  4 205-229 (IV)
  • 54 Tytgat G N, van Deventer S J. Pouchitis.  Int J Colorectal Dis. 1988;  3 226-228 (IV)
  • 55 MacMillan F, Warner A. Efficacy of immunosuppressive therapy for the treatment of chronic pouchitis following ileal pouch-anal anastomosis.  Am J Gastroenterol. 1999;  94 2677 (IV)
  • 56 Rowley S, Candinas D, Mayer A D. et al . Restorative proctocolectomy and pouch anal anastomosis for ulcerative colitis following orthotopic liver transplantation.  Gut. 1995;  37 845-847 (III)
  • 57 Zins B J, Sandborn W J, Penna C R. et al . Pouchitis disease course after orthotopic liver transplantation in patients with primary sclerosing cholangitis and an ileal pouch-anal anastomosis.  Am J Gastroenterol. 1995;  90 2177-2181 (III)
  • 58 Kuisma J, Luukkonen P, Jarvinen H. et al . Risk of osteopenia after proctocolectomy and ileal pouch-anal anastomosis for ulcerative colitis.  Scand J Gastroenterol. 2002;  37 171-176 (IIb)
  • 59 Heuschen U A, Heuschen G, Autschbach F. et al . Adenocarcinoma in the ileal pouch: late risk of cancer after restorative proctocolectomy.  Int J Colorectal Dis. 2001;  16 126-130 (IV)
  • 60 Iwama T, Kamikawa J, Higuchi T. et al . Development of invasive adenocarcinoma in a long-standing diverted ileal J-pouch for ulcerative colitis: report of a case.  Dis Colon Rectum. 2000;  43 101-104 (IV)
  • 61 Hassan C, Zullo A, Speziale G. et al . Adenocarcinoma of the ileoanal pouch anastomosis: an emerging complication?.  Int J Colorectal Dis. 2003;  18 276-278 (IV)
  • 62 Hyman N. Rectal cancer as a complication of stapled IPAA.  Inflamm Bowel Dis. 2002;  8 43-45 (IV)
  • 63 Puthu D, Rajan N, Rao R. et al . Carcinoma of the rectal pouch following restorative proctocolectomy. Report of a case.  Dis Colon Rectum. 1992;  35 257-260 (IV)
  • 64 Stern H, Walfisch S, Mullen B. et al . Cancer in an ileoanal reservoir: a new late complication?.  Gut. 1990;  31 473-475 (IV)
  • 65 Gullberg K, Lindforss U, Zetterquist H. et al . Cancer risk assessment in long-standing pouchitis. DNA aberrations are rare in transformed neoplastic pelvic pouch mucosa.  Int J Colorectal Dis. 2002;  17 92-97 (IV)

Prof. Dr. E. F. Stange

Robert-Bosch-Krankenhaus, Zentrum für Innere Medizin

Auerbachstraße 110

70376 Stuttgart

Phone: ++ 49/7 11/81 01 34 06

Fax: ++ 49/7 11/81 01 37 93

Email: eduard.stange@rbk.de